← Mechanisms of action
CD40LG
SINGLE PROTEINHomo sapiens
Preferred name: CD40 ligand ChEMBL ↗
Linked proteins
Drugs acting on this target (20)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| abbv-323 | Antagonist | experimental | mAb | CD40 ligand antagonist |
| lu ag22515 | Antagonist | experimental | Recombinant protein | CD40LG antagonist |
| vib4920 | Antagonist | experimental | mAb | CD40 ligand antagonist |
| bhv-1400 | Degrader | experimental | Small molecule | CD40LG degrader |
| isf35 | Immunity, active | experimental | Biological | CD40LG immunity, active |
| at-1501 | Inhibitor | experimental | mAb | CD40LG inhibitor |
| bms-986004 | Inhibitor | experimental | mAb | CD40LG inhibitor |
| bms-986090 | Inhibitor | experimental | mAb | CD40LG inhibitor |
| dapirolizumab pegol | Inhibitor | experimental | mAb | CD40LG inhibitor |
| gen1042 | Inhibitor | experimental | mAb | CD40LG inhibitor |
| imb071703 | Inhibitor | experimental | Recombinant protein | CD40LG inhibitor |
| jnj-64232025 | Inhibitor | experimental | mAb | CD40LG inhibitor |
| medi4920 | Inhibitor | experimental | Recombinant protein | CD40LG inhibitor |
| medi5083 | Inhibitor | experimental | Recombinant protein | CD40LG inhibitor |
| rhucd40l | Inhibitor | experimental | Recombinant protein | CD40LG inhibitor |
| ruplizumab | Inhibitor | experimental | mAb | CD40LG inhibitor |
| sar441236 | Inhibitor | experimental | mAb | CD40LG inhibitor |
| sar441344 | Inhibitor | experimental | mAb | CD40LG inhibitor |
| toralizumab | Inhibitor | experimental | mAb | CD40LG inhibitor |
| vib4920 | Inhibitor | experimental | mAb | CD40LG inhibitor |